279 related articles for article (PubMed ID: 26168919)
1. A comparison of two tests for filarial antigenemia in areas in Sri Lanka and Indonesia with low-level persistence of lymphatic filariasis following mass drug administration.
Yahathugoda TC; Supali T; Rao RU; Djuardi Y; Stefani D; Pical F; Fischer PU; Lloyd MM; Premaratne PH; Weerasooriya MV; Weil GJ
Parasit Vectors; 2015 Jul; 8():369. PubMed ID: 26168919
[TBL] [Abstract][Full Text] [Related]
2. Systematic sampling of adults as a sensitive means of detecting persistence of lymphatic filariasis following mass drug administration in Sri Lanka.
Rao RU; Samarasekera SD; Nagodavithana KC; Punchihewa MW; Ranasinghe USB; Weil GJ
PLoS Negl Trop Dis; 2019 Apr; 13(4):e0007365. PubMed ID: 31009482
[TBL] [Abstract][Full Text] [Related]
3. Reassessment of areas with persistent Lymphatic Filariasis nine years after cessation of mass drug administration in Sri Lanka.
Rao RU; Samarasekera SD; Nagodavithana KC; Dassanayaka TDM; Punchihewa MW; Ranasinghe USB; Weil GJ
PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006066. PubMed ID: 29084213
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive assessment of lymphatic filariasis in Sri Lanka six years after cessation of mass drug administration.
Rao RU; Nagodavithana KC; Samarasekera SD; Wijegunawardana AD; Premakumara WD; Perera SN; Settinayake S; Miller JP; Weil GJ
PLoS Negl Trop Dis; 2014; 8(11):e3281. PubMed ID: 25393404
[TBL] [Abstract][Full Text] [Related]
5. A multi-center field study of two point-of-care tests for circulating Wuchereria bancrofti antigenemia in Africa.
Chesnais CB; Awaca-Uvon NP; Bolay FK; Boussinesq M; Fischer PU; Gankpala L; Meite A; Missamou F; Pion SD; Weil GJ
PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005703. PubMed ID: 28892473
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Assessment of a Hotspot with Persistent Bancroftian Filariasis in Coastal Sri Lanka.
Rao RU; Samarasekera SD; Nagodavithana KC; Goss CW; Punchihewa MW; Dassanayaka TDM; Ranasinghe USB; Mendis D; Weil GJ
Am J Trop Med Hyg; 2018 Sep; 99(3):735-742. PubMed ID: 30014812
[TBL] [Abstract][Full Text] [Related]
7. How Thailand eliminated lymphatic filariasis as a public health problem.
Rojanapanus S; Toothong T; Boondej P; Thammapalo S; Khuanyoung N; Santabutr W; Prempree P; Gopinath D; Ramaiah KD
Infect Dis Poverty; 2019 May; 8(1):38. PubMed ID: 31130143
[TBL] [Abstract][Full Text] [Related]
8. Laboratory and field evaluation of a new rapid test for detecting Wuchereria bancrofti antigen in human blood.
Weil GJ; Curtis KC; Fakoli L; Fischer K; Gankpala L; Lammie PJ; Majewski AC; Pelletreau S; Won KY; Bolay FK; Fischer PU
Am J Trop Med Hyg; 2013 Jul; 89(1):11-15. PubMed ID: 23690552
[TBL] [Abstract][Full Text] [Related]
9. Identifying residual transmission of lymphatic filariasis after mass drug administration: Comparing school-based versus community-based surveillance - American Samoa, 2016.
Sheel M; Sheridan S; Gass K; Won K; Fuimaono S; Kirk M; Gonzales A; Hedtke SM; Graves PM; Lau CL
PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006583. PubMed ID: 30011276
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of effectiveness of diethylcarbamazine/albendazole combination in reduction of Wuchereria bancrofti infection using multiple infection parameters.
Wamae CN; Njenga SM; Ngugi BM; Mbui J; Njaanake HK
Acta Trop; 2011 Sep; 120 Suppl 1():S33-8. PubMed ID: 20933491
[TBL] [Abstract][Full Text] [Related]
11. Impact of five annual rounds of mass drug administration with diethylcarbamazine and albendazole on Wuchereria bancrofti infection in American Samoa.
Liang JL; King JD; Ichimori K; Handzel T; Pa'au M; Lammie PJ
Am J Trop Med Hyg; 2008 Jun; 78(6):924-8. PubMed ID: 18541771
[TBL] [Abstract][Full Text] [Related]
12. Human infection with sub-periodic Brugia spp. in Gampaha District, Sri Lanka: a threat to filariasis elimination status?
Mallawarachchi CH; Nilmini Chandrasena TGA; Premaratna R; Mallawarachchi SMNSM; de Silva NR
Parasit Vectors; 2018 Jan; 11(1):68. PubMed ID: 29378620
[TBL] [Abstract][Full Text] [Related]
13. The impact of repeated rounds of mass drug administration with diethylcarbamazine plus albendazole on bancroftian filariasis in Papua New Guinea.
Weil GJ; Kastens W; Susapu M; Laney SJ; Williams SA; King CL; Kazura JW; Bockarie MJ
PLoS Negl Trop Dis; 2008; 2(12):e344. PubMed ID: 19065257
[TBL] [Abstract][Full Text] [Related]
14. Molecular xenomonitoring as a post-MDA surveillance tool for global programme to eliminate lymphatic filariasis: Field validation in an evaluation unit in India.
Subramanian S; Jambulingam P; Krishnamoorthy K; Sivagnaname N; Sadanandane C; Vasuki V; Palaniswamy C; Vijayakumar B; Srividya A; Raju HKK
PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007862. PubMed ID: 31978060
[TBL] [Abstract][Full Text] [Related]
15. The impact of two semiannual treatments with albendazole alone on lymphatic filariasis and soil-transmitted helminth infections: a community-based study in the Republic of Congo.
Pion SD; Chesnais CB; Bopda J; Louya F; Fischer PU; Majewski AC; Weil GJ; Boussinesq M; Missamou F
Am J Trop Med Hyg; 2015 May; 92(5):959-66. PubMed ID: 25758650
[TBL] [Abstract][Full Text] [Related]
16. Surveillance for transmission of lymphatic filariasis in Colombo and Gampaha districts of Sri Lanka following mass drug administration.
Chandrasena NT; Premaratna R; Samarasekera DS; de Silva NR
Trans R Soc Trop Med Hyg; 2016 Dec; 110(10):620-622. PubMed ID: 27816936
[TBL] [Abstract][Full Text] [Related]
17. Programmatic Use of Molecular Xenomonitoring at the Level of Evaluation Units to Assess Persistence of Lymphatic Filariasis in Sri Lanka.
Rao RU; Samarasekera SD; Nagodavithana KC; Punchihewa MW; Dassanayaka TD; P K D G; Ford E; Ranasinghe US; Henderson RH; Weil GJ
PLoS Negl Trop Dis; 2016 May; 10(5):e0004722. PubMed ID: 27196431
[TBL] [Abstract][Full Text] [Related]
18. [Lymphatic filariasis transmission assessment survey in schools three years after stopping mass drug treatment with albendazole and ivermectin in the 7 endemic districts in Togo].
Dorkenoo AM; Sodahlon YK; Bronzan RN; Yakpa K; Sossou E; Ouro-Medeli A; Teko M; Seim A; Mathieu E
Bull Soc Pathol Exot; 2015 Aug; 108(3):181-7. PubMed ID: 25476256
[TBL] [Abstract][Full Text] [Related]
19. Prolonged persistence of residual Wuchereria bancrofti infection after cessation of diethylcarbamazine-fortified salt programme.
Ramaiah KD; Thiruvengadam B; Vanamail P; Subramanian S; Gunasekaran S; Nilamani N; Das PK
Trop Med Int Health; 2009 Aug; 14(8):870-6. PubMed ID: 19552662
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of annual single doses of diethylcarbamazine citrate among bancroftian filariasis infected individuals in an endemic area under mass drug administration in Brazil.
da Silva JSF; Braga C; Duarte FM; Oliveira P; Feitosa Luna C; Marcondes M; Araújo J; Grilis MR; de Souza Melo PFA; Brandão E; Rocha A
Pathog Glob Health; 2018 Jul; 112(5):274-280. PubMed ID: 30111259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
